CN101342303B - 治疗糖尿病的纯天然药物 - Google Patents
治疗糖尿病的纯天然药物 Download PDFInfo
- Publication number
- CN101342303B CN101342303B CN200810212253XA CN200810212253A CN101342303B CN 101342303 B CN101342303 B CN 101342303B CN 200810212253X A CN200810212253X A CN 200810212253XA CN 200810212253 A CN200810212253 A CN 200810212253A CN 101342303 B CN101342303 B CN 101342303B
- Authority
- CN
- China
- Prior art keywords
- percent
- blood
- radix
- diabetes
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 8
- 206010012601 diabetes mellitus Diseases 0.000 title abstract description 15
- 239000009636 Huang Qi Substances 0.000 claims abstract description 7
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 7
- 235000008434 ginseng Nutrition 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 8
- 239000012567 medical material Substances 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- 241000208340 Araliaceae Species 0.000 claims description 6
- 240000002900 Arthrospira platensis Species 0.000 claims description 6
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 6
- 241000657665 Rhopilema esculentum Species 0.000 claims description 6
- 241001620634 Roger Species 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 229940082787 spirulina Drugs 0.000 claims description 6
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 4
- 102000011759 adducin Human genes 0.000 claims description 3
- 108010076723 adducin Proteins 0.000 claims description 3
- 238000001514 detection method Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 235000013312 flour Nutrition 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000002386 leaching Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 230000003068 static effect Effects 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 16
- 210000004369 blood Anatomy 0.000 abstract description 16
- 230000006870 function Effects 0.000 abstract description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract description 6
- 102000004877 Insulin Human genes 0.000 abstract description 4
- 108090001061 Insulin Proteins 0.000 abstract description 4
- 229940125396 insulin Drugs 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 230000004203 pancreatic function Effects 0.000 abstract description 2
- 230000003394 haemopoietic effect Effects 0.000 abstract 2
- 208000003643 Callosities Diseases 0.000 abstract 1
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 208000002249 Diabetes Complications Diseases 0.000 abstract 1
- 206010012655 Diabetic complications Diseases 0.000 abstract 1
- 206010020649 Hyperkeratosis Diseases 0.000 abstract 1
- 240000002948 Ophiopogon intermedius Species 0.000 abstract 1
- 241000237502 Ostreidae Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241001530038 Pantherophis obsoletus Species 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241000242583 Scyphozoa Species 0.000 abstract 1
- 240000008042 Zea mays Species 0.000 abstract 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 235000005822 corn Nutrition 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 235000020636 oyster Nutrition 0.000 abstract 1
- 230000003863 physical function Effects 0.000 abstract 1
- 230000003248 secreting effect Effects 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 210000002700 urine Anatomy 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000002651 drug therapy Methods 0.000 description 3
- 208000030159 metabolic disease Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010027336 Menstruation delayed Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000008839 Kidney Neoplasms Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- JLRGJRBPOGGCBT-UHFFFAOYSA-N Tolbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1 JLRGJRBPOGGCBT-UHFFFAOYSA-N 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 239000004026 insulin derivative Substances 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229940100691 oral capsule Drugs 0.000 description 1
- ICFJFFQQTFMIBG-UHFFFAOYSA-N phenformin Chemical compound NC(=N)NC(=N)NCCC1=CC=CC=C1 ICFJFFQQTFMIBG-UHFFFAOYSA-N 0.000 description 1
- 229940023488 pill Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 229960005371 tolbutamide Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗糖尿病的纯天然药物，其重量百分比为：人参5％、黄芪5％、麦冬5％、五味子5％、熟地5％、山萸5％、茯苓5％、花粉5％、知母5％、螺旋藻5％、黄连5％、海蛰8％、牡蛎8％、海文蛤8％、乌梢蛇10％其余为拟黑多刺蚁。通过正血改善造血微环境，恢复造血功能，全面增强机体功能，包括胰脏功能得以恢复，分泌足够的胰岛素，纠正糠代谢紊乱，使血糠正常，血液正常，使糠尿病的多种并发症随之消失，获得康复。本发明具有益髓生血，活血化瘀，恢复血液正常等功能，主治糖尿病。
Description
技术领域
本发明涉及人类疑难病代谢疾病即糖尿病，具体说涉及一种提取海洋生物和多种动植物药材有效成份组成的治疗糖尿病的纯天然药物制剂。
背景技术
糖尿病是一种人类内分泌代谢疾病，因胰岛素分泌不足或绝对不足而引起糖代谢紊乱，以血糖增高为主要特征；是一种常见病，多发病。临床分为I、II型糖尿病，II型糖尿病更为广泛，且发生率更高。晚期患者常伴有高血压、心脑血管病、肾病、肿瘤、失明等多种并发症状。严重影响人类的生存质量和寿命。发病率有续年增高的势头。目前全球广泛使用胰岛素、甲糖宁、降糖灵等药物治疗，临床有一定的疗效，但只治标未能治本，终生使用也不能治愈。因此，亟待开发出一种可以从根本上治疗糖尿病的纯天然药物。
发明内容
本发明的目的在于通过提供一种治疗糖尿病的纯天然药物，以治本为主，恢复机体功能使内分泌正常，糖代谢正常，治愈糠尿病。及其并发症，使患者全面康复。
本发明是采用以下技术手段实现的：
一种治疗糖尿病的纯天然药物，其重量百分比为：人参5％、黄芪5％、麦冬5％、五味子5％、熟地5％、山萸5％、茯苓5％、花粉5％、知母5％、螺旋藻5％、黄连5％、海蛰8％、牡蛎8％、海文蛤8％、乌梢蛇10％其余为拟黑多刺蚁。
上述纯天然药物的制备方法，依配方称取：螺旋藻、海蛰、牡蛎、海文蛤、乌梢蛇、拟黑多刺蚁，经粉碎后使用65％乙醇液逆流提取后，经过滤取清液回收乙醇，得流浸膏，经烘干备用；
按方称取：黄芪、麦冬、五味子、熟地、山萸、茯苓、花粉、知母、黄连药材，粉碎成粒粗，经用逆流提取法，离心过滤后，加热浓缩至密度1.25，后加95％乙醇，酒沉，静止24小时，抽取清液回收乙醇，得清膏，烘干备用；将人参单独粉碎过100目筛，成细粉备用；将以上所得混合碎粉、配料、搅拌、检测、分装即得成品。
前述的药物是硬胶囊、或颗粒剂、或片剂、或丸剂、或散剂。
本发明一种治疗糖尿病的纯天然药物，与现有技术相比，具有以下明显的优势和有益效果：
本发明一种治疗糖尿病的纯天然药物，以发明人创立的《正血医学》理论为基础，提取海、陆多种动、植物药材有效成份组成的纯天然药物，通过正血(治血)改善造血微环境，恢复造血功能，全面增强机体功能，包括胰脏功能得以恢复，分泌足够的胰岛素，纠正糠代谢紊乱，使血糠正常，血液正常，使糠尿病的多种并发症随之消失，获得康复。本发明具有益髓生血，活血化瘀，恢复血液正常等功能，主治糖尿病。临床试验170例II型糠尿病，获得显著疗效。显著率78％，总有效率达到97.8％，无毒副作用。
具体实施方式
下面结合具体实施例加以说明：
一种治疗糖尿病的纯天然药物，按配方组成称取药材配制：
1、依配方称取：螺旋藻、海蛰、牡蛎、海文蛤、乌梢蛇、拟黑多刺蚁等药材，经粉碎后使用65％乙醇液逆流提取后，经过滤取清液回收乙醇，得流浸膏，经烘干备用；
2、按方称取：黄芪、麦冬、五味子、熟地、山萸、茯苓、花粉、知母、黄连等药材，粉碎成粒粗，经用逆流提取法，离心过滤后，加热浓缩至密度1.25，后加95％乙醇，酒沉，静止24小时，抽取清液回收乙醇，得清膏，烘干备用；
3、将人参单独粉碎过100目筛，成细粉备用；
4、将1、2、3项所得干粉，混合碎粉、配料、搅拌、检测、装胶囊即得成品。
5、口服胶囊粒重0.25g，成人3粒/次，3次/日。
经过以上配制好的一种治疗糖尿病的纯天然药物，在每1000g总质量中：人参50g、黄芪50g、麦冬50g、五味子50g、熟地50g、山萸50g、茯苓50g、花粉50g、知母50g、螺旋藻50g、黄连50g海蛰80g、牡蛎80g、海文蛤80g、乌梢蛇100g其余为拟黑多刺蚁。
以上配方经临床试验170例II型糠尿病，获得显著疗效。显著率78％，总有效率达到97.8％，无毒副作用。
以下以几个典型病例进行说明：
冯某某，女，58岁，农民，诊断为II型晚期糠尿病已五年，随机血糠>12mmol/L，甲状腺功亢进，高血压、心脏病、消瘦、两足坏疽、视力不清、失眠、行走困难等症状。使用胰岛素治疗三年未见好转。后用本项药物治疗一个月后，症状改善，服用6个月后，血糠正常，上述症状及并发症状全部消失。身体康复。
王某某，男，47岁，国家干部，诊断为II型晚期糠尿病，随机血糠>13.55mmol/L，伴有高脂血症、心率不齐、肾肿瘤3.2cm×2.7cm、四肢麻木、视力不清、胸闷、腰痛、头晕、失眠等症状，使用胰岛素等药物治疗3年5个月未见好转。使用本项发明治疗两个月大有改善，连服药1年后，血糠正常，上述症状消失，全面康复。
最后应说明的是：以上实施例仅用以说明本发明而并非限制本发明所描述的技术方案；因此，尽管本说明书参照上述的各个实施例对本发明已进行了详细的说明，但是，本领域的普通技术人员应当理解，仍然可以对本发明进行修改或等同替换；而一切不脱离发明的精神和范围的技术方案及其改进，其均应涵盖在本发明的权利要求范围当中。
Claims (2)
1.一种治疗II型糖尿病的纯天然药物，其特征在于：重量百分比为：人参5％、黄芪5％、麦冬5％、五味子5％、熟地5％、山萸5％、茯苓5％、花粉5％、知母5％、螺旋藻5％、黄连5％、海蛰8％、牡蛎8％、海文蛤8％、乌梢蛇10％、其余为拟黑多刺蚁；
制备时，依配方称取：螺旋藻、海蛰、牡蛎、海文蛤、乌梢蛇、拟黑多刺蚁，经粉碎后使用65％乙醇液逆流提取后，经过滤取清液回收乙醇，得流浸膏，经烘干备用；按方称取：黄芪、麦冬、五味子、熟地、山萸、茯苓、花粉、知母、黄连药材，粉碎成粒粗，经用逆流提取法，离心过滤后，加热浓缩至密度1.25，后加95％乙醇，酒沉，静止24小时，抽取清液回收乙醇，得清膏，经烘干备用；将人参单独粉碎过100目筛，成细粉备用；将以上所得混合碎粉、配料、搅拌、检测、分装即得成品。
2.根据权利要求1所述的治疗II型糖尿病的纯天然药物，其特征在于：所述的药物是硬胶囊、或颗粒剂、或片剂、或丸剂、或散剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810212253XA CN101342303B (zh) | 2008-09-08 | 2008-09-08 | 治疗糖尿病的纯天然药物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810212253XA CN101342303B (zh) | 2008-09-08 | 2008-09-08 | 治疗糖尿病的纯天然药物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101342303A CN101342303A (zh) | 2009-01-14 |
| CN101342303B true CN101342303B (zh) | 2012-12-26 |
Family
ID=40244495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200810212253XA Expired - Fee Related CN101342303B (zh) | 2008-09-08 | 2008-09-08 | 治疗糖尿病的纯天然药物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101342303B (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101569408B (zh) * | 2009-04-23 | 2012-12-26 | 湛江市贤博科技有限公司 | 一种促进人类健康的纯天然食品 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1099630A (zh) * | 1993-08-31 | 1995-03-08 | 天津市第三中心医院 | 胰活散冲剂 |
| CN1106271A (zh) * | 1994-02-01 | 1995-08-09 | 张树成 | 糖尿康导引袋的配制方法 |
| CN101095753A (zh) * | 2007-07-05 | 2008-01-02 | 北京艺信堂医药研究所 | 治疗糖尿病性高脂血症的一种中药制剂 |
-
2008
- 2008-09-08 CN CN200810212253XA patent/CN101342303B/zh not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1099630A (zh) * | 1993-08-31 | 1995-03-08 | 天津市第三中心医院 | 胰活散冲剂 |
| CN1106271A (zh) * | 1994-02-01 | 1995-08-09 | 张树成 | 糖尿康导引袋的配制方法 |
| CN101095753A (zh) * | 2007-07-05 | 2008-01-02 | 北京艺信堂医药研究所 | 治疗糖尿病性高脂血症的一种中药制剂 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101342303A (zh) | 2009-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1047946C (zh) | 老年病制剂 | |
| CN101229355B (zh) | 风湿汤 | |
| CN100536888C (zh) | 一种治疗慢性肾炎、肾病综合征的中药制剂 | |
| CN102488743A (zh) | 中药组合物、制备方法及中药制剂 | |
| CN102657736B (zh) | 一种治疗类风湿性关节炎的药物组合物及其制备方法 | |
| CN1970021A (zh) | 一种治疗痛风病的中药及其制备方法 | |
| CN108042766A (zh) | 一种补肾通络养脑膏及其制备方法 | |
| CN101342303B (zh) | 治疗糖尿病的纯天然药物 | |
| CN102973758A (zh) | 一种治疗抑郁症的中药组合物 | |
| CN104258359A (zh) | 一种用于治疗妊娠反应的中药组合物及其制剂的制备方法 | |
| CN100525821C (zh) | 一种治疗尿床病的中药及其制备方法 | |
| CN102526664A (zh) | 一种治疗脾胃不和、脘腹胀痛的药物 | |
| CN102988740A (zh) | 一种治疗糖尿病的中草药配方 | |
| CN102698131A (zh) | 一种治疗糖尿病的胶囊 | |
| CN103405574B (zh) | 一种治疗高血压的药物组合物 | |
| CN104274800A (zh) | 治疗胃病的药物及其制备方法 | |
| CN102580023A (zh) | 一种治疗脾胃不和、脘腹胀痛的药物 | |
| CN102488851A (zh) | 治疗反复发作生殖器疱疹的药物及其制备方法 | |
| CN112755137B (zh) | 一种治疗轻中度膝骨关节炎的中药组合物及其应用 | |
| CN103182048A (zh) | 一种治疗肾阳虚证的口服药藿阳补肾胶囊及其制备方法 | |
| CN101167986B (zh) | 消酸去痛养胃胶囊 | |
| CN1094371C (zh) | 一种治疗白血病的组合药物 | |
| CN104840759A (zh) | 一种用于治疗消化不良的药物制剂 | |
| CN1060677C (zh) | 老年病制剂 | |
| CN104208620A (zh) | 一种抗病毒制剂及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: ZHANGJIANG XIANBO SCIENCE + TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: MO YIXIAN Effective date: 20110131 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 524044 NO.91 (ZHANJIANG XIANBO TECHNOLOGY CO., LTD.), NORTH OF HAIBIN AVENUE, ZHANJIANG CITY, GUANGDONG PROVINCE TO: 524044 ROOM 806, NO.61, SOUTH OF HAIBIN AVENUE, DEVELOPMENT AREA, ZHANJIANG CITY, GUANGDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20110131 Address after: 806, room 61, 524044, Haibin Avenue, Zhanjiang Development Zone, Guangdong, China Applicant after: ZHANJIANG XIANBO TECHNOLOGY Co.,Ltd. Address before: 524044, No. 91, Haibin Avenue, Zhanjiang City, Guangdong province (Zhanjiang Yin Bo Technology Co., Ltd.) Applicant before: Mo Yixian |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20090114 Assignee: Beijing century fraternity Medical Institute, Limited by Share Ltd. Assignor: ZHANJIANG XIANBO TECHNOLOGY Co.,Ltd. Contract record no.: 2014990000815 Denomination of invention: Pure natural medicament for treating diabetes Granted publication date: 20121226 License type: Exclusive License Record date: 20141024 |
|
| LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20200506 Address after: Room 1115, building 1, Evergrande oasis garden, No. 12, Haiwan South Road, Potou District, Zhanjiang City, Guangdong Province Patentee after: Zhanjiang Tiantai Pharmaceutical Technology Co.,Ltd. Address before: 806, room 61, 524044, Haibin Avenue, Zhanjiang Development Zone, Guangdong, China Patentee before: ZHANJIANG XIANBO TECHNOLOGY Co.,Ltd. |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121226 Termination date: 20210908 |